Brooks Laboratories’ arm gets marketing authorization for Meropenem in Germany

29 Nov 2021 Evaluate

Brooks Laboratories’ subsidiary company -- Brooks Steriscience has received marketing authorisation for antibacterial drug Meropenem in Germany. This is the first marketing authorisation received by the Brooks Steriscience in the European region. Vadodara facility of Brooks Steriscience has received marketing authorisation in Germany for Meropenem.

Brooks Laboratories is a pharmaceutical contract research and manufacturing services company.

Brooks Laboratories Share Price

62.90 4.20 (7.16%)
10-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1813.00
Dr. Reddys Lab 1313.90
Cipla 1333.10
Zydus Lifesciences 922.90
Lupin 2340.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×